Malaria recombinant poxvirus vaccine

Details Malaria recombinant poxvirus vaccine Malaria recombinant poxvirus vaccine

C - Chemistry, Metallurgy

12

N

C12N 7/01 (2006.01) A61K 31/70 (2006.01) A61K 39/015 (2006.01) C07K 14/445 (2006.01) C12N 15/30 (2006.01) C12N 15/86 (2006.01) C12N 15/863 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2106464

2106464 9216616 PCTABS00016 What is described is a recombinant poxvirus, such as vaccinia or canarypox virus, containing foreign DNA from Plasmodium. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. Preferred recombinants have attenuated virulence.

Affiliated with

Also associated with

Rating

Malaria recombinant poxvirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Malaria recombinant poxvirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Malaria recombinant poxvirus vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1981587